Eli Lilly pauses trial of antibody drug over safety concern
U.S. drugmaker Eli Lilly said that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by President Donald Trump has been paused because of a safety concern.
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook